<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000579605"><TermName>recombinant human interleukin-2</TermName><TermPronunciation>(ree-KOM-bih-nunt HYOO-mun in-ter-LOO-kin...)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat some types of cancer. It is a form of interleukin-2, a cytokine made by leukocytes (white blood cells), that is made in the laboratory.  Recombinant human interleukin-2 increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes. It is a type of biological response modifier.  Also called aldesleukin and Proleukin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720423" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;recombinant human interleukin-2&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720422" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina 2 humana genotecnológica&quot;" language="es" id="_4"/><SpanishTermName>interleucina 2 humana genotecnológica</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar algunos tipos de cáncer. Es una forma de interleucina-2, una citocina elaborada por los leucocitos (glóbulos blancos), que se produce en el laboratorio. La interleucina 2 humana genotecnológica aumenta la actividad y el crecimiento de los glóbulos blancos que se llaman linfocitos T y linfocitos B. Es un tipo de modificador de la respuesta biológica. También se llama aldesleucina y Proleukin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-11-30</DateFirstPublished><DateLastModified>2008-11-07</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000596071">Aldesleukin</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
